Victory Capital Management’s Cellebrite CLBT Stock Holding History

Victory Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$208K	Buy	14,256 +946	+7%	+$12.5K	﹤0.01%	2258
2026 Q1	$183K	Buy	13,310 +163	+1%	+$2.46K	﹤0.01%	2206
2025 Q4	$237K	Buy	13,147 +602	+5%	+$10.8K	﹤0.01%	2165
2025 Q3	$232K	Sell	12,545 -447	-3%	-$7.02K	﹤0.01%	2197
2025 Q2	$208K	Buy	+12,992	New	+$232K	﹤0.01%	2241
2025 Q1	–	Sell	-10,640	Closed	-$234K	–	2483
2024 Q4	$234K	Buy	+10,640	New	+$205K	﹤0.01%	2189

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Victory Capital Management's CLBT Position: Q2 2026 in Review

Victory Capital Management increased its Cellebrite (CLBT) stake by 7.1% in Q2 2026, buying an estimated $12.5K and bringing the position to 14,256 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

Victory Capital Management first reported a position in CLBT in Q4 2024 and has held it in 6 quarters since. The position peaked at $237K in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Victory Capital Management held 14,256 shares of Cellebrite worth $208K as of Q2 2026.
Victory Capital Management bought 946 Cellebrite shares in Q2 2026, an estimated $12.5K.
Cellebrite made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2258 holding.
Victory Capital Management first reported a position in Cellebrite in Q4 2024 and has held it in 6 quarters since.
Victory Capital Management's Cellebrite position peaked at $237K in Q4 2025.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.